Who Buys Bhasma from India — 146 Importers Behind a $414.6K Market
India's bhasma import market is served by 146 active buyers who collectively imported $414.6K across 720 shipments. PLANET PHARMA SA (FRANCE) leads with a 7.4% market share, followed by AYUSHAKTI B V and FARMAMIR LLC. The top 5 buyers together control 26.5% of total import value, reflecting a moderately competitive buyer landscape.
Top Bhasma Importers — Ranked by Import Value
PLANET PHARMA SA (FRANCE) is the leading bhasma importer from India, holding a 7.4% share of the $414.6K market across 720 shipments from 146 buyers. The top 5 buyers — PLANET PHARMA SA (FRANCE), AYUSHAKTI B V (NETHERLANDS), FARMAMIR LLC (KYRGYZSTAN), PATANJALI AYURVED PRIVATE LIMITED (NEPAL), MEGA MEDI IMPEX PVT.LTD (NEPAL) — collectively control 26.5% of total import value.
Top Bhasma Buyers & Importers
Ranked by import value · 146 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | PLANET PHARMA SAFRANCE LIVERHEAL 52 | $30.8K | 5 | 7.4% |
| 2 | AYUSHAKTI B VNETHERLANDS | $26.9K | 5 | 6.5% |
| 3 | FARMAMIR LLCKYRGYZSTAN | $18.9K | 5 | 4.6% |
| 4 | PATANJALI AYURVED PRIVATE LIMITEDNEPAL ASPATIC BHASMAABHRAK BHASMASUVARNA SVARNA BHASMA 100 MG | $17.7K | 5 | 4.3% |
| 5 | MEGA MEDI IMPEX PVT.LTDNEPAL ASPATIC BHASMAABHRAK BHASMASUVARNA SVARNA BHASMA 100 MG | $15.8K | 5 | 3.8% |
| 6 | MEGA MEDI IMPEX PVT LTDNEPAL ASPATIC BHASMAABHRAK BHASMASUVARNA SVARNA BHASMA 100 MG | $14.9K | 5 | 3.6% |
| 7 | TRINITY CONSULTANTSUNITED KINGDOM SHANKH BHASMA ITEM INFO CODE - ABHN006100% NATURAL HERB EXTRACTS - SHANKH BHASMA100% NATURAL HERB EXTRACTS FOR ANIMAL FEED :- SHANKH BHASMA | $12.1K | 5 | 2.9% |
| 8 | LUNA TRADING CO.PVT.LTDNEPAL ASPATIC BHASMAABHRAK BHASMASUVARNA SVARNA BHASMA 100 MG | $12.0K | 5 | 2.9% |
| 9 | PATANJALI AYURVED PVT LTDNEPAL ASPATIC BHASMAABHRAK BHASMASUVARNA SVARNA BHASMA 100 MG | $11.6K | 5 | 2.8% |
| 10 | NEMAN # PHARM LLCKYRGYZSTAN | $11.0K | 5 | 2.6% |
| 11 | AL YANBOU CHEMICALS TRADING CO.LLCUNITED ARAB EMIRATES ASPATIC BHASMAABHRAK BHASMASUVARNA SVARNA BHASMA 100 MG | $10.2K | 5 | 2.5% |
| 12 | SANTHIGRAM KERALA AYURVEDIC CO OFUNITED STATES AYURVEDA PRODUCTS - ABHRAKABHASMAM CAPGODANTI BHASMAAYURVEDIC PRODUCTS - SHANKABHASMAM CAPNOS | $8.7K | 5 | 2.1% |
| 13 | MEGA MEDI IMPEX PVT. LTD.NEPAL ASPATIC BHASMAABHRAK BHASMASUVARNA SVARNA BHASMA 100 MG | $8.4K | 5 | 2.0% |
| 14 | DABUR NEPAL PRIVATE LIMITEDNEPAL ASPATIC BHASMAABHRAK BHASMASUVARNA SVARNA BHASMA 100 MG | $7.9K | 5 | 1.9% |
| 15 | GRACE PHARMACEUTICALS P. LTD.NEPAL ASPATIC BHASMAABHRAK BHASMASUVARNA SVARNA BHASMA 100 MG | $7.4K | 5 | 1.8% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Bhasma — and from which countries?
Flow of Bhasma exports from India: each country's share and the named importers behind the numbers
Bhasma — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1Nepal
Nepal emerges as the first largest importing country, achieving a total trade value of $145.6K through 169 shipments. This represents a market share of 35.1% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Nepal has a diverse importer base, with their top importers including:
• PATANJALI AYURVED PRIVATE LIMITED - $17.7K (12.2% of country's total business)
• MEGA MEDI IMPEX PVT.LTD - $15.8K (10.9% of country's total business)
• MEGA MEDI IMPEX PVT LTD - $14.9K (10.2% of country's total business)
• LUNA TRADING CO.PVT.LTD - $12.0K (8.3% of country's total business)
• PATANJALI AYURVED PVT LTD - $11.6K (7.9% of country's total business)
• Rest of Nepal's importers - $73.6K (50.5% of country's total business)
Key Insight: Nepal demonstrates strong market positioning with an average shipment value of $862, indicating premium pricing strategy compared to the market average of $576.
Nepal is a key market for Bhasma imports, representing 35.1% of total trade value.
2United Arab Emirates
United Arab Emirates emerges as the second largest importing country, achieving a total trade value of $55.8K through 8 shipments. This represents a market share of 13.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United Arab Emirates has a diverse importer base, with their top importers including:
• AL YANBOU CHEMICALS TRADING CO.LLC - $10.2K (18.2% of country's total business)
Key Insight: United Arab Emirates demonstrates strong market positioning with an average shipment value of $7.0K, indicating premium pricing strategy compared to the market average of $576.
United Arab Emirates is a key market for Bhasma imports, representing 13.5% of total trade value.
3Kyrgyzstan
Kyrgyzstan emerges as the third largest importing country, achieving a total trade value of $42.3K through 12 shipments. This represents a market share of 10.2% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Kyrgyzstan has a diverse importer base, with their top importers including:
• FARMAMIR LLC - $18.9K (44.6% of country's total business)
• NEMAN # PHARM LLC - $11.0K (25.9% of country's total business)
Key Insight: Kyrgyzstan demonstrates strong market positioning with an average shipment value of $3.5K, indicating premium pricing strategy compared to the market average of $576.
Kyrgyzstan is a key market for Bhasma imports, representing 10.2% of total trade value.
4Dominican Republic
Dominican Republic emerges as the fourth largest importing country, achieving a total trade value of $33.2K through 0 shipments. This represents a market share of 8.0% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Dominican Republic demonstrates strong market positioning with an average shipment value of $33.2K, indicating premium pricing strategy compared to the market average of $576.
Dominican Republic is a key market for Bhasma imports, representing 8.0% of total trade value.
5France
France emerges as the fifth largest importing country, achieving a total trade value of $30.8K through 2 shipments. This represents a market share of 7.4% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: France has a diverse importer base, with their top importers including:
• PLANET PHARMA SA - $30.8K (99.7% of country's total business)
Key Insight: France demonstrates strong market positioning with an average shipment value of $15.4K, indicating premium pricing strategy compared to the market average of $576.
France is a key market for Bhasma imports, representing 7.4% of total trade value.
Buyer Segment Analysis
TransData Nexus Bhasma buyer market intelligence
1Buyer Segment Analysis
The importation of Bhasma from India involves various buyer segments, each with distinct purchasing behaviors:
- Distributors: Entities like PLANET PHARMA SA (France) and AYUSHAKTI B V (Netherlands) function as intermediaries, procuring Bhasma in bulk to supply to retailers, healthcare facilities, and practitioners. Their purchasing patterns are characterized by large, periodic orders to maintain a steady supply chain.
- Retail Chains: Companies such as MEGA MEDI IMPEX PVT.LTD (Nepal) and LUNA TRADING CO.PVT.LTD (Nepal) operate retail outlets offering Bhasma directly to consumers. They typically place regular, smaller orders aligned with consumer demand and inventory turnover rates.
- Re-exporters: Firms like TRINITY CONSULTANTS (United Kingdom) may import Bhasma with the intent to re-export to other markets, leveraging their strategic locations and trade networks. Their order sizes and frequencies can vary based on market demand and trade agreements.
- Contract Manufacturers: Entities such as FARMAMIR LLC (Kyrgyzstan) might import Bhasma as a raw material for producing finished pharmaceutical products. Their procurement is often project-based, with orders corresponding to production schedules and client contracts.
Understanding these segments is crucial for tailoring marketing strategies and supply chain logistics to meet the specific needs and behaviors of each buyer type.
Country-Specific Import Regulations
TransData Nexus Bhasma buyer market intelligence
1Country-Specific Import Regulations
Import regulations for Bhasma (HS Code: 30049011) vary across the top importing countries:
- Nepal:
- Regulatory Authority: Department of Drug Administration (DDA).
- Import Registration Process: Importers must obtain a Drug Import License from the DDA, requiring submission of product details, manufacturer's information, and a certificate of analysis.
- Estimated Timeline: Approximately 30-45 days.
- Import Tariff/Duty: Typically ranges from 5% to 10%, subject to change based on government policies.
- United Arab Emirates (UAE):
- Regulatory Authority: Ministry of Health and Prevention (MOHAP).
- Import Registration Process: Requires product registration with MOHAP, including submission of technical documents, free sale certificates, and compliance with Gulf Cooperation Council (GCC) standards.
- Estimated Timeline: Approximately 60-90 days.
- Import Tariff/Duty: Generally 5% for pharmaceutical products.
- Kyrgyzstan:
- Regulatory Authority: Department of Drug Provision and Medical Equipment under the Ministry of Health.
- Import Registration Process: Importers must obtain a license, adhering to the Eurasian Economic Union (EAEU) regulations, which include product registration and quality certification.
- Estimated Timeline: Approximately 45-60 days.
- Import Tariff/Duty: As a member of the EAEU, Kyrgyzstan applies a common external tariff, typically around 5% for pharmaceuticals.
- Dominican Republic:
- Regulatory Authority: General Directorate of Medicines, Food, and Health Products (DIGEMAPS) under the Ministry of Public Health.
- Import Registration Process: Requires a Sanitary Registration, involving submission of product dossiers, free sale certificates, and compliance with local labeling requirements.
- Estimated Timeline: Approximately 60-90 days.
- Import Tariff/Duty: Generally 8% for pharmaceutical products.
- France:
- Regulatory Authority: French National Agency for Medicines and Health Products Safety (ANSM).
- Import Registration Process: Requires marketing authorization from ANSM, including submission of comprehensive technical documentation and compliance with European Union (EU) regulations.
- Estimated Timeline: Approximately 90-120 days.
- Import Tariff/Duty: As an EU member, France applies a 0% tariff on pharmaceutical products from countries with trade agreements; otherwise, tariffs may apply.
Importers should consult the respective regulatory authorities for the most current and detailed requirements.
Demand Drivers & Market Opportunity
TransData Nexus Bhasma buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Bhasma in importing countries is influenced by several factors:
- Traditional Medicine Practices: In countries like Nepal and Kyrgyzstan, traditional medicine systems such as Ayurveda and Unani are integral to healthcare. Bhasma, being a component of these systems, sees consistent demand.
- Government Healthcare Programs: Some governments incorporate traditional medicines into their national healthcare programs, promoting the use of products like Bhasma. For instance, Nepal's Ministry of Health and Population has initiatives supporting Ayurvedic treatments.
- Universal Health Coverage Expansion: Efforts to achieve universal health coverage often include traditional medicines, increasing accessibility and demand for products like Bhasma.
- WHO Essential Medicines List Procurement: While Bhasma is not listed on the WHO Essential Medicines List, its inclusion in national essential medicines lists can drive procurement through government tenders.
- Tender-Based Purchasing: Public health facilities in countries like Nepal often procure medicines through tender systems. A study highlighted challenges in the procurement process, affecting the availability of essential medicines.
With 146 buyers across 34 countries, the market for Bhasma presents opportunities for growth, particularly in regions with strong traditional medicine practices and supportive government policies.
Common Questions — Bhasma Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest bhasma buyer importing from India?
Based on import volume and value, PLANET PHARMA SA (FRANCE) leads with $30.8K in imports and a 7.4% market share — the highest of any single bhasma importer. AYUSHAKTI B V (NETHERLANDS) and FARMAMIR LLC (KYRGYZSTAN) are the next largest buyers.
QHow many companies buy bhasma from India?
There are 146 active bhasma buyers importing from India, with a combined market of $414.6K across 720 shipments to 34 countries. The top 5 buyers hold 26.5% of total import value, while the remaining 141 buyers handle the other 73.5%.
QWhich countries import the most bhasma from India?
The top importing countries for bhasma from India are Nepal (35.1%), United Arab Emirates (13.5%), Kyrgyzstan (10.2%), Dominican Republic (8.0%), France (7.4%). These markets represent the largest demand centres for Indian pharmaceutical exports of bhasma, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for bhasma from India?
The average import transaction value for bhasma from India is $576, with an average unit price of $10.88 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Bhasma buyer market intelligence
1Buyer Segment Analysis
The importation of Bhasma from India involves various buyer segments, each with distinct purchasing behaviors:
- Distributors: Entities like PLANET PHARMA SA (France) and AYUSHAKTI B V (Netherlands) function as intermediaries, procuring Bhasma in bulk to supply to retailers, healthcare facilities, and practitioners. Their purchasing patterns are characterized by large, periodic orders to maintain a steady supply chain.
- Retail Chains: Companies such as MEGA MEDI IMPEX PVT.LTD (Nepal) and LUNA TRADING CO.PVT.LTD (Nepal) operate retail outlets offering Bhasma directly to consumers. They typically place regular, smaller orders aligned with consumer demand and inventory turnover rates.
- Re-exporters: Firms like TRINITY CONSULTANTS (United Kingdom) may import Bhasma with the intent to re-export to other markets, leveraging their strategic locations and trade networks. Their order sizes and frequencies can vary based on market demand and trade agreements.
- Contract Manufacturers: Entities such as FARMAMIR LLC (Kyrgyzstan) might import Bhasma as a raw material for producing finished pharmaceutical products. Their procurement is often project-based, with orders corresponding to production schedules and client contracts.
Understanding these segments is crucial for tailoring marketing strategies and supply chain logistics to meet the specific needs and behaviors of each buyer type.
Country-Specific Import Regulations
TransData Nexus Bhasma buyer market intelligence
1Country-Specific Import Regulations
Import regulations for Bhasma (HS Code: 30049011) vary across the top importing countries:
- Nepal:
- Regulatory Authority: Department of Drug Administration (DDA).
- Import Registration Process: Importers must obtain a Drug Import License from the DDA, requiring submission of product details, manufacturer's information, and a certificate of analysis.
- Estimated Timeline: Approximately 30-45 days.
- Import Tariff/Duty: Typically ranges from 5% to 10%, subject to change based on government policies.
- United Arab Emirates (UAE):
- Regulatory Authority: Ministry of Health and Prevention (MOHAP).
- Import Registration Process: Requires product registration with MOHAP, including submission of technical documents, free sale certificates, and compliance with Gulf Cooperation Council (GCC) standards.
- Estimated Timeline: Approximately 60-90 days.
- Import Tariff/Duty: Generally 5% for pharmaceutical products.
- Kyrgyzstan:
- Regulatory Authority: Department of Drug Provision and Medical Equipment under the Ministry of Health.
- Import Registration Process: Importers must obtain a license, adhering to the Eurasian Economic Union (EAEU) regulations, which include product registration and quality certification.
- Estimated Timeline: Approximately 45-60 days.
- Import Tariff/Duty: As a member of the EAEU, Kyrgyzstan applies a common external tariff, typically around 5% for pharmaceuticals.
- Dominican Republic:
- Regulatory Authority: General Directorate of Medicines, Food, and Health Products (DIGEMAPS) under the Ministry of Public Health.
- Import Registration Process: Requires a Sanitary Registration, involving submission of product dossiers, free sale certificates, and compliance with local labeling requirements.
- Estimated Timeline: Approximately 60-90 days.
- Import Tariff/Duty: Generally 8% for pharmaceutical products.
- France:
- Regulatory Authority: French National Agency for Medicines and Health Products Safety (ANSM).
- Import Registration Process: Requires marketing authorization from ANSM, including submission of comprehensive technical documentation and compliance with European Union (EU) regulations.
- Estimated Timeline: Approximately 90-120 days.
- Import Tariff/Duty: As an EU member, France applies a 0% tariff on pharmaceutical products from countries with trade agreements; otherwise, tariffs may apply.
Importers should consult the respective regulatory authorities for the most current and detailed requirements.
Demand Drivers & Market Opportunity
TransData Nexus Bhasma buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Bhasma in importing countries is influenced by several factors:
- Traditional Medicine Practices: In countries like Nepal and Kyrgyzstan, traditional medicine systems such as Ayurveda and Unani are integral to healthcare. Bhasma, being a component of these systems, sees consistent demand.
- Government Healthcare Programs: Some governments incorporate traditional medicines into their national healthcare programs, promoting the use of products like Bhasma. For instance, Nepal's Ministry of Health and Population has initiatives supporting Ayurvedic treatments.
- Universal Health Coverage Expansion: Efforts to achieve universal health coverage often include traditional medicines, increasing accessibility and demand for products like Bhasma.
- WHO Essential Medicines List Procurement: While Bhasma is not listed on the WHO Essential Medicines List, its inclusion in national essential medicines lists can drive procurement through government tenders.
- Tender-Based Purchasing: Public health facilities in countries like Nepal often procure medicines through tender systems. A study highlighted challenges in the procurement process, affecting the availability of essential medicines.
With 146 buyers across 34 countries, the market for Bhasma presents opportunities for growth, particularly in regions with strong traditional medicine practices and supportive government policies.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 146 global importers of Bhasma identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 720 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 34 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
720 Verified Shipments
146 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists